Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Dexterra Group Inc. Announces Results for Q4 and Year Ended December 31, 2024

In This Article:

Toronto, Ontario--(Newsfile Corp. - March 6, 2025) - Dexterra Group Inc. (TSX: DXT)

Highlights

  • Dexterra generated strong results from continuing operations for 2024 with consolidated revenue of $1.0 billion, an increase of 8.1% compared to the prior year. The increase in revenue was due to organic growth, strong natural resource market activity levels and the contribution from the CMI Management LLC ("CMI") acquisition. For Q4 2024, Dexterra generated consolidated revenue of $247.8 million, an increase of $16.6 million, compared to Q4 2023. The increase was driven by the above, partially offset by lower camp demobilization and installation project activity in Asset Based Services ("ABS") compared to Q4 2023.

  • Adjusted EBITDA from continuing operations for 2024 was $107.4 million (2023 - $106.8 million). Support Services ("SS") EBITDA rose significantly to a record $74.1 million, an increase of 36.8%. This was offset by lower 2024 EBITDA from ABS as expected due to the abnormal level of wildfire activity in 2023. These 2024 developments were consistent with management's plans to increase the scale and profitability of the Support Services business. Adjusted EBITDA for Q4 2024 was $26.6 million compared to $23.6 million in Q4 2023. This increase is a result of stronger revenues and margins in Support Services offset by lower volumes in ABS as several large projects were demobilized in Q4 2023.

  • Free Cash Flow ("FCF") was $74.7 million for the year ended December 31, 2024, compared to $57.8 million in 2023. The Adjusted EBITDA conversion to FCF was 69.5% as compared to 54.1% in the prior year and reflected strong operating results and working capital management and nominal cash taxes payable as the company utilized tax loss carryforwards.

  • For the three months and year ended December 31, 2024, net earnings from continuing operations were $7.6 million and $37.5 million, respectively, compared to $8.3 million and $35.8 million in 2023. Our continuing operations delivered a return on equity of 13.3% in 2024 and 12.5% in 2023. Earnings per share from continuing operations was $0.58 cents in 2024 compared to $0.55 cents in 2023.

  • In connection with the ongoing Normal Course Issuer Bid ("NCIB"), Dexterra purchased and cancelled 1,177,100 common shares in 2024 at a weighted average price of $6.72 per share for a total consideration of $7.9 million. Dexterra plans to remain opportunistic with share buybacks in 2025 as we believe our shares are undervalued.

  • Dexterra paid dividends of $0.35 during the year and declared a dividend for Q1 2025 of $0.0875 per share for shareholders of record at March 31, 2025, to be paid April 15, 2025.

  • In Q4 2024, Dexterra repositioned its business from an operational and external segmented reporting perspective into SS and ABS.


Waiting for permission
Allow microphone access to enable voice search

Try again.